摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2.2'-Bis-salicylidenamino-diphenyl | 113550-96-2

中文名称
——
中文别名
——
英文名称
2.2'-Bis-salicylidenamino-diphenyl
英文别名
disalicylidene-biphenyl-2,2'-diyldiamine;Disalicyliden-biphenyl-2,2'-diyldiamin;2-[[2-[2-[(2-Hydroxyphenyl)methylideneamino]phenyl]phenyl]iminomethyl]phenol
2.2'-Bis-salicylidenamino-diphenyl化学式
CAS
113550-96-2
化学式
C26H20N2O2
mdl
——
分子量
392.457
InChiKey
FSAXBAHFNLUDGR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    153-154 °C
  • 沸点:
    671.1±55.0 °C(Predicted)
  • 密度:
    1.15±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.4
  • 重原子数:
    30
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    65.2
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    一种双SalenAl配合物及其制备方法和应用
    摘要:
    本发明公开了一种双SalenAl配合物及其制备方法和应用,属于精细化学品和配合物合成及催化应用技术领域。本发明通过在SalenAl配合物的溶液中添加另一分子Salen骨架的辅助配体L2,或在反应器中同时添加Salen骨架的配体L1和L2、AlR3、溶剂反应制得双SalenAl配合物。本发明获得的配合物具有价格低廉、毒性低、不含重金属和有害物质和对环境污染小等特点。本发明制备配合物过程中具备条件温和,操作简单,后处理方便等优势,是具有良好应用前景的催化剂体系。
    公开号:
    CN117659072A
  • 作为产物:
    描述:
    参考文献:
    名称:
    Diastereoisomeric four-coordinate complexes. V. Pseudo-tetrahedral complexes of controlled absolute configuration. Configurational interconversion of nickel(II) complexes withour racemization
    摘要:
    DOI:
    10.1021/ja01019a009
点击查看最新优质反应信息

文献信息

  • Vanadium(<scp>iii</scp>) phenoxyimine complexes for ethylene or ε-caprolactone polymerization: mononuclear versus binuclear pre-catalysts
    作者:Lucy Clowes、Mark Walton、Carl Redshaw、Yimin Chao、Alex Walton、Pertti Elo、Victor Sumerin、David L. Hughes
    DOI:10.1039/c2cy20571h
    日期:——
    The mononuclear [C6H4NCH(ArO)]2VCl(THF)} (Ar = 2,4-t-Bu2C6H2 (1), Ar = C6H4 (2)), O[C6H4NCH(ArO)]2}VCl(THF) (Ar = 2,4-t-Bu2C6H2 (3), Ar = C6H4 (4)) and the binuclear vanadium(III) complexes [C6H4NCH(ArO)]VCl2(THF)2}2(μ-CH2CH2) (Ar = 2,4-t-Bu2C6H2 (5), Ar = C6H4 (6)), have been synthesized and fully characterized. The compounds [C6H5NCH(ArO)]VCl2(THF)2 (Ar = 2,4-t-Bu2C6H2 (7), Ar = C6H4 (8)), [2,4,6-Me3–C6H2NCH(ArO)]VCl2 (Ar = 2,4-t-Bu2C6H2 (9), Ar = C6H4 (10)) and [2,6-i-Pr2-C6H3NCH(ArO)]VCl2(THF)2 (Ar = 2,4-t-Bu2C6H2 (11), Ar = C6H4 (12)), μ-CH2CH2[NCH(C6H4O)]2VCl(THF)} (14) and C6H4[NCH(C6H4O)]2VCl(THF)} (15) were synthesized for comparative polymerization studies. The dizwitterionic compound [2,6-i-Pr2-C6H3N+(H)CH(C6H4O)]2VCl2O (13) was also isolated, and presumably formed via a fortuitous hydrolysis reaction. The complexes 2, 5 and 13 have been structurally characterized; the molecular structure of the parent ligand (L5) in 5 is also reported. All complexes have been screened for ethylene as well as ε-caprolactone polymerization, and results are compared against those for known related mono- and bi-nuclear counterparts to evaluate for possible cooperative effects. The compounds 10 and 12 have been supported on modified SiO2, analysed by XPS and subjected to homo-polymerization (ethylene) and co-polymerization (1-hexene and ethylene) studies.
    合成并全面表征了单核化合物[ NCH(ArO)]2VCl(THF)} (Ar = 2,4-t-Bu2C6H2 (1),Ar = C6H4 (2))和O[ NCH(ArO)]2}VCl(THF) (Ar = 2,4-t-Bu2C6H2 (3),Ar = (4)),以及双核(III)络合物[ NCH(ArO)]VCl2(THF)2}2(μ-CH2CH2) (Ar = 2,4-t-Bu2C6H2 (5),Ar = (6))。合成了化合物[C6H5NCH(ArO)]VCl2(THF)2 (Ar = 2,4-t-Bu2C6H2 (7),Ar = (8))、[2,4,6-Me3–C6H2NCH(ArO)]VCl2 (Ar = 2,4-t-Bu2C6H2 (9),Ar = (10))和[2,6-i-Pr2- CH(ArO)]VCl2(THF)2 (Ar = 2,4-t-Bu2C6H2 (11),Ar = (12)),μ-CH2CH2[NCH( O)]2VCl(THF)} (14)和 [NCH( O)]2VCl(THF)} (15),以进行比较聚合研究。二盐型化合物[2,6-i-Pr2-C6H3N+(H)CH( O)]2VCl2O (13)也被分离出来,推测是在一次偶然的解反应中形成的。化合物2、5和13已被结构表征;化合物5中母体配体(L5)的分子结构也被报告。所有络合物均已检测乙烯ε-己内酯聚合的能力,并将结果与已知相关的单核和双核对照进行比较,以评估可能的协同效应。化合物10和12被支持在改性SiO2上,通过XPS分析,并进行了均聚合(乙烯)和共聚合(1-己烯乙烯)研究。
  • A Four-coördinated Copper(II) Complex with a Tetrahedral Disposition of the Copper Valences
    作者:Francis Lions、Kenneth V. Martin
    DOI:10.1021/ja01563a002
    日期:1957.3
  • New manganese(II) and copper(II) complexes of tetradentate N2O2 schiff base ligands
    作者:S.M. Abu-el-wafa、F.M. Ashmawy、R.M. Issa、C.A. McAuliffe、R.V. Parish
    DOI:10.1016/s0020-1693(00)93726-5
    日期:1985.1
  • Synthetic Study of Symmetrical and Unsymmetrical Schiff Base Complexes of VO(IV) and Mn(III) Derived from 2,2′‐Diaminobiphenyl
    作者:Davar M. Boghaei、Mahdi Behzad
    DOI:10.1081/sim-200055230
    日期:2005.5.1
    The symmetrical and unsymmetrical Schiff base complexes of VO( IV) and Mn( III) derived from 2,20-diaminobiphenyl and derivatives of salicylaldehyde and 1-hydroxy-2-naphthaldehyde have been synthesized and characterized by elemental analysis, NMR, infrared and electronic absorption spectroscopies, and conductivity measurements. The reaction of the ligands with oxovanadium( IV) was found to be kinetically unfavored, probably due to the small ionic radius of the metal ion, which is not in accordance with the cavity size of the ligands.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫